Literature DB >> 17000080

Clinical review of three types of platysma myocutaneous flap.

T Su1, Y-F Zhao, B Liu, Y-P Hu, W-F Zhang.   

Abstract

This study evaluated the survival rates of three types of platysma myocutaneous flap: transverse flap, vertical flap that preserved the facial artery and vein and vertical flap that sacrificed the facial artery and vein. Modified radical or supraomohyoid neck dissection was also performed in all patients. Out of 54 patients, transverse and vertical flaps were used for 12 and 42 cases, respectively. In 42 cases of vertical flaps, 26 cases preserved the facial artery and vein, 16 cases sacrificed them. Ten cases of the transverse flaps survived and two cases had partial necrosis. In the 26 cases of vertical flaps that preserved the facial artery and vein, 23 cases survived and three cases had partial necrosis. With the 16 cases of vertical flaps that sacrificed the facial artery and vein, 10 cases survived, four cases had partial necrosis and two cases had total necrosis. The flap survival rates were 83.3, 88.5 and 62.5%, respectively, in the transverse, vertical flap preserving the facial vessels and vertical flap that sacrificed them. The survival rates of transverse and vertical platysma myocutaneous flaps preserving the facial artery and vein were higher than vertical flap that sacrificed the facial artery and vein.

Entities:  

Mesh:

Year:  2006        PMID: 17000080     DOI: 10.1016/j.ijom.2006.08.002

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  11 in total

1.  Closure of defects after resection of tumors of the oral cavity and the pharynx: medium- to long-term oncologic and functional results with the myocutaneous platysma flap.

Authors:  Julian Künzel; Heinrich Iro; Georgios Psychogios; Johannes Zenk; Michael Koch
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-09       Impact factor: 2.503

2.  [The central island tongue flap for the reconstruction of the anterior floor of the mouth].

Authors:  J D Raguse; A Bezeluk; J Bier; M Klein
Journal:  Mund Kiefer Gesichtschir       Date:  2007-01

3.  Defect closure after oral and pharyngeal tumor resection with the superiorly pedicled myocutaneous platysma flap: indications, technique, and complications.

Authors:  Michael Koch; Julian Künzel; Konstantinos Mantsopoulos; Johannes Zenk; Heinrich Iro
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-24       Impact factor: 2.503

4.  The posterosuperiorly based platysmal myocutaneous flap: the underutilized reconstructive option.

Authors:  Rahul K Thakkur; Shrey R Pandya
Journal:  J Maxillofac Oral Surg       Date:  2013-12-24

Review 5.  Platysma myocutaneous flap - its current role in reconstructive surgery of oral soft tissue defects.

Authors:  André M Eckardt
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2013-02-21

6.  Platysma flap: an alternative to free flaps.

Authors:  Mònica Lafont Rufat; Bartolomé Nadal Cristobal; Esther Saura Fillat; Domingo Ruiz de la Cuesta Martín
Journal:  J Maxillofac Oral Surg       Date:  2013-02-17

7.  Single stage reconstructions in head and neck surgery using deltopectoral and pectoralis major myocutaneous flaps.

Authors:  Bibhuti B Nayak; Mohanty Nilamani
Journal:  Indian J Plast Surg       Date:  2012-01

8.  Vertical platysma myocutaneous flap that sacrifices the facial artery and vein.

Authors:  Zhen-ning Li; Rui-wu Li; Fa-yu Liu; Qi-gen Fang; Xu Zhang; Chang-fu Sun
Journal:  World J Surg Oncol       Date:  2013-07-24       Impact factor: 2.754

9.  Clinical reliability of radial forearm free flap in repair of buccal defects.

Authors:  Qi-Gen Fang; Zhen-Ning Li; Xu Zhang; Fa-Yu Liu; Zhong-Fei Xu; Chang-Fu Sun
Journal:  World J Surg Oncol       Date:  2013-01-30       Impact factor: 2.754

10.  Submental versus platysma flap for the reconstruction of complex facial defects following resection of head and neck tumors.

Authors:  Jawad Safdar; Fa-Yu Liu; Yousuf Moosa; Zhong-Fei Xu; Zhen-Ning Li; Chang-Fu Sun
Journal:  Pak J Med Sci       Date:  2014-07       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.